Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Puglisi

Showing results (71-80 of 126) with videos related to

Pageof 13
Sort By:
Breast Cancer Research and Treatment|November 4, 2005
Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancerM Venturini, C Bighin, S Monfardini, et al.
Clinical & Experimental Metastasis|June 19, 2013
Risk factors and survival outcomes in patients with brain metastases from breast cancerA M Minisini, S Moroso, L Gerratana, et al.
Cancer Treatment Reviews|October 11, 2021
Emerging molecular alterations leading to histology-specific targeted therapies in ovarian cancer beyond PARP inhibitorsM Bartoletti, L Musacchio, G Giannone, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 29, 2008
Information to cancer patients: a questionnaire survey in three different geographical areas in ItalyR Bracci, E Zanon, R Cellerino, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|March 8, 2016
Long-acting insulin analog detemir displays reduced effects on adipocyte differentiation of human subcutaneous and visceral adipose stem cellsA Cignarelli, S Perrini, P Nigro, et al.
Journal of Clinical Pathology|October 17, 2007
Expression of periostin in human breast cancerF Puglisi, C Puppin, E Pegolo, et al.
British Journal of Cancer|September 24, 2004
Phase II study of a triplet regimen in advanced colorectal cancer using methotrexate, oxaliplatin and 5-fluorouracilA Guglielmi, S Barni, A Zaniboni, et al.
ESMO Open|December 15, 2023
Discontinuation rate and serious adverse events of chemoimmunotherapy as neoadjuvant treatment for triple-negative breast cancer: a systematic review and meta-analysisA Rizzo, F M Schipilliti, F Di Costanzo, et al.
ESMO Open|May 1, 2025
Precision oncology in biliary tract cancer: the emerging role of liquid biopsyM de Scordilli, M Bortolot, S Torresan, et al.
Anticancer Research|March 26, 2002
Prognostic significance of Ape1/ref-1 subcellular localization in non-small cell lung carcinomasF Puglisi, G Aprile, A M Minisini, et al.
Pageof 13

Showing results (71-80 of 126) with videos related to

Sort By:
Pageof 13
Breast Cancer Research and Treatment|November 4, 2005
Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancerM Venturini, C Bighin, S Monfardini, et al.
Clinical & Experimental Metastasis|June 19, 2013
Risk factors and survival outcomes in patients with brain metastases from breast cancerA M Minisini, S Moroso, L Gerratana, et al.
Cancer Treatment Reviews|October 11, 2021
Emerging molecular alterations leading to histology-specific targeted therapies in ovarian cancer beyond PARP inhibitorsM Bartoletti, L Musacchio, G Giannone, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 29, 2008
Information to cancer patients: a questionnaire survey in three different geographical areas in ItalyR Bracci, E Zanon, R Cellerino, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|March 8, 2016
Long-acting insulin analog detemir displays reduced effects on adipocyte differentiation of human subcutaneous and visceral adipose stem cellsA Cignarelli, S Perrini, P Nigro, et al.
Journal of Clinical Pathology|October 17, 2007
Expression of periostin in human breast cancerF Puglisi, C Puppin, E Pegolo, et al.
British Journal of Cancer|September 24, 2004
Phase II study of a triplet regimen in advanced colorectal cancer using methotrexate, oxaliplatin and 5-fluorouracilA Guglielmi, S Barni, A Zaniboni, et al.
ESMO Open|December 15, 2023
Discontinuation rate and serious adverse events of chemoimmunotherapy as neoadjuvant treatment for triple-negative breast cancer: a systematic review and meta-analysisA Rizzo, F M Schipilliti, F Di Costanzo, et al.
ESMO Open|May 1, 2025
Precision oncology in biliary tract cancer: the emerging role of liquid biopsyM de Scordilli, M Bortolot, S Torresan, et al.
Anticancer Research|March 26, 2002
Prognostic significance of Ape1/ref-1 subcellular localization in non-small cell lung carcinomasF Puglisi, G Aprile, A M Minisini, et al.
Pageof 13